Gene Editing
HIV vaccine being developed by Johnson & Johnson fails clinical trial
Yet another experimental HIV vaccine has failed.
The National Institute of Allergy and Infectious Diseases reported Wednesday that a phase 3 clinical trial of a vaccine was stopped because the vaccine was ineffective at preventing HIV infection. The vaccine was being developed by Janssen, the vaccine division of Johnson & Johnson.
